Natrecor Recommended Use Initiative Differs Slightly From Panel Advice

Scios' new educational materials for Natrecor (nesiritide) will recommend use of the drug for hospitalized patients with either dyspnea at rest or minimal activity - a slight departure from advice offered by a panel of experts recently convened by the Johnson & Johnson subsidiary